Medication adherence in schizophrenia

David Roberts, Dawn I Velligan

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Antipsychotic medications enable many individuals with schizophrenia to live more rewarding and productive lives. However, this benefit hinges on patients taking medications as prescribed, and as many as half of all patients exhibit some degree of treatment nonadherence. The current review summarizes the results of a survey on medication nonadherence that was completed by 41 experts in the field. Results confirm the prevalence of the problem, and provide practical guidance for clinicians on measurement and management of nonadherence.

Original languageEnglish (US)
Pages (from-to)11-15
Number of pages5
JournalDrug Discovery Today: Therapeutic Strategies
Volume8
Issue number1-2
DOIs
StatePublished - Jun 2012

Fingerprint

Medication Adherence
Schizophrenia
Antipsychotic Agents
Therapeutics
Surveys and Questionnaires

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Molecular Medicine

Cite this

Medication adherence in schizophrenia. / Roberts, David; Velligan, Dawn I.

In: Drug Discovery Today: Therapeutic Strategies, Vol. 8, No. 1-2, 06.2012, p. 11-15.

Research output: Contribution to journalArticle

Roberts, David ; Velligan, Dawn I. / Medication adherence in schizophrenia. In: Drug Discovery Today: Therapeutic Strategies. 2012 ; Vol. 8, No. 1-2. pp. 11-15.
@article{f5e2ea76cb344a55bc2c094017e4ae6f,
title = "Medication adherence in schizophrenia",
abstract = "Antipsychotic medications enable many individuals with schizophrenia to live more rewarding and productive lives. However, this benefit hinges on patients taking medications as prescribed, and as many as half of all patients exhibit some degree of treatment nonadherence. The current review summarizes the results of a survey on medication nonadherence that was completed by 41 experts in the field. Results confirm the prevalence of the problem, and provide practical guidance for clinicians on measurement and management of nonadherence.",
author = "David Roberts and Velligan, {Dawn I}",
year = "2012",
month = "6",
doi = "10.1016/j.ddstr.2011.10.001",
language = "English (US)",
volume = "8",
pages = "11--15",
journal = "Drug Discovery Today: Therapeutic Strategies",
issn = "1740-6773",
publisher = "Elsevier Limited",
number = "1-2",

}

TY - JOUR

T1 - Medication adherence in schizophrenia

AU - Roberts, David

AU - Velligan, Dawn I

PY - 2012/6

Y1 - 2012/6

N2 - Antipsychotic medications enable many individuals with schizophrenia to live more rewarding and productive lives. However, this benefit hinges on patients taking medications as prescribed, and as many as half of all patients exhibit some degree of treatment nonadherence. The current review summarizes the results of a survey on medication nonadherence that was completed by 41 experts in the field. Results confirm the prevalence of the problem, and provide practical guidance for clinicians on measurement and management of nonadherence.

AB - Antipsychotic medications enable many individuals with schizophrenia to live more rewarding and productive lives. However, this benefit hinges on patients taking medications as prescribed, and as many as half of all patients exhibit some degree of treatment nonadherence. The current review summarizes the results of a survey on medication nonadherence that was completed by 41 experts in the field. Results confirm the prevalence of the problem, and provide practical guidance for clinicians on measurement and management of nonadherence.

UR - http://www.scopus.com/inward/record.url?scp=84862196935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862196935&partnerID=8YFLogxK

U2 - 10.1016/j.ddstr.2011.10.001

DO - 10.1016/j.ddstr.2011.10.001

M3 - Article

VL - 8

SP - 11

EP - 15

JO - Drug Discovery Today: Therapeutic Strategies

JF - Drug Discovery Today: Therapeutic Strategies

SN - 1740-6773

IS - 1-2

ER -